Bioaffinity Technologies, INC. (BIAFW) — 8-K Filings

All 8-K filings from Bioaffinity Technologies, INC.. Browse 47 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (47)

bioAffinity Technologies Files 8-K — Dec 22, 2025 Risk: low
On December 22, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing indicates that the company is involved in commercial physical and biologica
bioAffinity Technologies Files 8-K — Dec 19, 2025 Risk: low
On December 19, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing indicates that the company is involved in commercial physical and biologica
8-K Filing — Dec 3, 2025
8-K Filing — Nov 5, 2025
bioAffinity Technologies Files 8-K — Oct 28, 2025 Risk: low
On October 28, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," i
bioAffinity Technologies Files 8-K — Oct 20, 2025 Risk: low
On October 20, 2025, bioAffinity Technologies, Inc. filed a Form 8-K to report other events and financial statements. The company, incorporated in Delaware with
bioAffinity Technologies Files 8-K — Oct 16, 2025 Risk: low
On October 16, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential u
bioAffinity Technologies Files 8-K — Oct 15, 2025 Risk: low
bioAffinity Technologies, Inc. filed an 8-K on October 15, 2025, reporting on events that occurred on October 14, 2025. The filing includes information on finan
bioAffinity Technologies Files 8-K with Material Agreement — Oct 9, 2025 Risk: medium
On October 8, 2025, bioAffinity Technologies, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and fina
bioAffinity Technologies Files 8-K — Oct 7, 2025 Risk: low
On October 7, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing indicates no specific material events or financial updates were disclosed on
bioAffinity Technologies Files 8-K — Sep 30, 2025 Risk: medium
On September 29, 2025, bioAffinity Technologies, Inc. entered into a material definitive agreement. The company also reported other events and filed financial s
bioAffinity Technologies Files 8-K on Corporate Changes — Sep 17, 2025 Risk: low
On September 17, 2025, bioAffinity Technologies, Inc. filed an 8-K report detailing material modifications to security holder rights, amendments to its articles
bioAffinity Technologies Files 8-K — Sep 9, 2025 Risk: medium
On September 9, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits,"
bioAffinity Technologies to be Acquired — Sep 5, 2025 Risk: medium
bioAffinity Technologies, Inc. announced on September 5, 2025, that it has entered into a definitive agreement to be acquired by an unaffiliated third party. Th
bioAffinity Technologies Files 8-K — Sep 3, 2025 Risk: low
On September 3, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits,"
bioAffinity Technologies Files 8-K — Sep 2, 2025 Risk: medium
On September 2, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing indicates the company entered into a material definitive agreement and also
bioAffinity Technologies Announces Board and Executive Changes — Aug 18, 2025 Risk: medium
bioAffinity Technologies, Inc. announced on August 12, 2025, a change in its board of directors and executive compensation arrangements. The filing details the
bioAffinity Technologies Faces Delisting Concerns — Aug 13, 2025 Risk: high
bioAffinity Technologies, Inc. filed an 8-K on August 13, 2025, reporting events as of August 7, 2025. The filing indicates a notice of delisting or failure to
bioAffinity Technologies Files 8-K — Jul 31, 2025 Risk: low
bioAffinity Technologies, Inc. filed an 8-K on July 31, 2025, reporting events as of July 29, 2025. The filing includes information on "Other Events" and "Finan
bioAffinity Technologies Files 8-K on Security Holder Vote Matters — Jul 25, 2025 Risk: low
On July 25, 2025, bioAffinity Technologies, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, incorporated
bioAffinity Technologies Files 8-K — Jul 23, 2025 Risk: low
On July 23, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. No specific
bioAffinity Technologies Files 8-K — Jul 22, 2025 Risk: low
On July 22, 2025, bioAffinity Technologies, Inc. filed a Form 8-K to report other events and financial statements. The company, incorporated in Delaware with it
bioAffinity Technologies Files 8-K Report — Jul 15, 2025 Risk: low
On July 15, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 3300 Nacogdo
bioAffinity Technologies Faces Delisting Notice — May 30, 2025 Risk: high
bioAffinity Technologies, Inc. filed an 8-K on May 30, 2025, reporting a notice of delisting or failure to satisfy continued listing rules as of May 27, 2025. T
bioAffinity Technologies Enters Material Definitive Agreement — May 27, 2025 Risk: medium
On May 22, 2025, bioAffinity Technologies, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive
bioAffinity Technologies Files 8-K on Shareholder Nominations — May 19, 2025 Risk: medium
On May 19, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily concerns shareholder nominations pursuant to Exchange Act Rule 14a-11,
bioAffinity Technologies Files 8-K — May 8, 2025 Risk: medium
On May 5, 2025, bioAffinity Technologies, Inc. entered into a material definitive agreement. The company also reported other events and filed financial statemen
bioAffinity Technologies Announces Board and CFO Changes — Apr 14, 2025 Risk: medium
On April 12, 2025, bioAffinity Technologies, Inc. announced changes in its board of directors and executive compensation. The company elected two new directors,
bioAffinity Technologies Closes $1.5M Private Placement — Mar 7, 2025 Risk: medium
On March 6, 2025, bioAffinity Technologies, Inc. filed an 8-K report detailing several events. The company announced the closing of a private placement offering
bioAffinity Technologies Files 8-K with Key Agreements — Feb 27, 2025 Risk: medium
On February 25, 2025, bioAffinity Technologies, Inc. filed an 8-K report detailing several events. These include entering into a material definitive agreement,
bioAffinity Technologies Faces Delisting Notice — Feb 7, 2025 Risk: high
bioAffinity Technologies, Inc. filed an 8-K on February 7, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company is
bioAffinity Tech Appoints New Director, CEO Gets New Contract — Jan 14, 2025 Risk: medium
On January 10, 2025, bioAffinity Technologies, Inc. announced changes in its board of directors and executive compensation. Specifically, the company elected Dr
bioAffinity Technologies Files 8-K on Shareholder Vote — Dec 23, 2024 Risk: medium
bioAffinity Technologies, Inc. filed an 8-K on December 23, 2024, reporting on a matter submitted to a vote of security holders on December 20, 2024. The filing
bioAffinity Technologies Files 8-K — Dec 20, 2024 Risk: low
On December 19, 2024, bioAffinity Technologies, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includ
bioAffinity Technologies Files 8-K with Material Agreements — Oct 21, 2024 Risk: medium
On October 17, 2024, bioAffinity Technologies, Inc. entered into a material definitive agreement, likely related to financing or a strategic partnership. The co
bioAffinity Technologies Adds Director — Oct 10, 2024 Risk: medium
On October 4, 2024, bioAffinity Technologies, Inc. announced the election of Dr. Maria Elena Zavala to its Board of Directors. Dr. Zavala brings extensive exper
bioAffinity Technologies Files 8-K — Oct 9, 2024 Risk: low
On October 9, 2024, bioAffinity Technologies, Inc. filed an 8-K report detailing a Regulation FD Disclosure and other events. The filing includes financial stat
bioAffinity Technologies Files 8-K on Shareholder Vote Matters — Oct 7, 2024 Risk: medium
bioAffinity Technologies, Inc. filed an 8-K on October 7, 2024, reporting on a submission of matters to a vote of security holders that occurred on October 2, 2
bioAffinity Technologies Files 8-K on Director Changes — Aug 23, 2024 Risk: medium
On August 19, 2024, bioAffinity Technologies, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includ
bioAffinity Technologies Files 8-K with Key Corporate Updates — Aug 5, 2024 Risk: medium
On August 2, 2024, bioAffinity Technologies, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The
bioAffinity Technologies Files 8-K Report — Jul 9, 2024 Risk: medium
On July 9, 2024, bioAffinity Technologies, Inc. filed an 8-K report detailing significant events. The filing includes information on the company's results of op
bioAffinity Technologies Reports Director Changes and Bylaw Amendments — Jun 5, 2024 Risk: medium
bioAffinity Technologies, Inc. filed an 8-K on June 4, 2024, reporting several key events. These include the departure of directors, election of new directors,
bioAffinity Technologies Files 8-K on Financials — May 16, 2024 Risk: low
bioAffinity Technologies, Inc. filed an 8-K on May 15, 2024, reporting on its results of operations and financial condition. The filing includes financial state
bioAffinity CFO Resigns, Interim Appointed — Mar 13, 2024 Risk: medium
On March 8, 2024, bioAffinity Technologies, Inc. filed an 8-K report detailing the resignation of its Chief Financial Officer, Dr. Robert L. Uhl, effective Marc
bioAffinity Technologies Files 8-K on Equity Sales — Mar 8, 2024 Risk: medium
On March 6, 2024, bioAffinity Technologies, Inc. entered into a material definitive agreement related to the sale of unregistered equity securities. The company
bioAffinity Technologies Files 8-K — Mar 5, 2024 Risk: low
On March 5, 2024, bioAffinity Technologies, Inc. filed an 8-K report detailing its financial results and operations. The company, incorporated in Delaware, is i
bioAffinity Tech Reports Leadership Changes, Comp Arrangements — Jan 31, 2024
bioAffinity Technologies, Inc. filed an 8-K on January 31, 2024, reporting an event that occurred on January 26, 2024, related to the departure or election of d

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX